Cosmetic Surgery Market Report by Gender (Female and Male), Age Group (13 to 29, 30 to 54 and 54 and above), Procedure (Surgical Procedure, Non-Surgical Procedure), End User (Ambulatory Surgical Facility, Hospital and Clinic, Office and Cosmetic Surgical Center), Regions and Company Analysis 2024-2032

Cosmetic Surgery Market Outlook

Global Cosmetic Surgery Market was worth US$ 69.93 Billion in 2023, and it will grow at a CAGR of 9.95% from 2024 to 2032. There, it will likely be valued at US$ 164.22 Billion by 2032.

Cosmetic surgery, often referred to as delicate surgery, makes better or worsens a person's look. It consists of a range of non-invasive and surgical techniques that help people feel good about themselves, correct physical deformities or asymmetries, improve the appearance of scars or other skin defects, and improve their physical image. The demand for these operations is driven by the growth of cosmetic and medical vacations, increased investments in making health infrastructure, and the building of high-quality health amenities.

Every year, more and more people turn to beauty operations to improve their image. In addition, a large patient group in need of treatment and the growing frequency of dermal disturbances are driving up demand for these actions.  For instance, as per a World Health Organization report published in 2023, there are about 1.8 billion individuals worldwide dealing with a range of skin sicknesses, including acne, eczema, psoriasis, and skin cancer, at any given time. 
According to data released by the British Skin Organization, almost 60% of people in the United Kingdom had a skin issue in 2020. However, more patients will have these operations done due to the development of new skin problem treatment ways and equipment and better payment guidelines for cosmetics. In addition, many people prefer painless ways to appear young and robust. This element is driving up requests for non-surgical.

Market Driver Growing Trend in Youth and Aging Population Beauty Operation Procedures:

Global market flows will be driven by the desire to look good and the awareness of fitness among the young and old. There will be a greater need for beauty actions in the coming years due to the growing acceptance of beautiful treatments among developed nations. The global market for beauty surgery will grow as procedures like fat removal, poison injections, and nose changes become increasingly common.

In essence, The American Society of Plastic Physicians (ASPS) communicated in 2020 that participants did 15,595,955 delicate surgery operations. This included 13,281,235 minimally invasive procedures like soft tissue filler injections, neuromodulator injections, and chemical peels and about 2,314,720 cosmetic surgeries like fat removal, skin tightening, eye surgery, and nose.

Growing Demand for Fewer Invasive Beauty Operations:

Injectable facial fillers and botulinum poison are two examples of minimally invasive actions used in beauty surgery. It has extended dramatically over the past ten years and is expected to support the market during the calculation. There has been a significant demand for these actions in the US for several years. 

The beauty of delicate surgery lies in its double gains. It helps clients achieve their wanted image, bringing them closer to their natural self and improving their physical health. Take rhinoplasty, for example. Besides enhancing the look and shape of their nose, it can also remove any respiratory issues they may be facing.

Technological progress, such as the release of Revance's RHA (resilient hyaluronic acid) filler line in August 2020, is playing an essential part in the growth of the cosmetic surgery market. These new hyaluronic acid fillers, the first step in a range of beautiful treatments, are designed to adapt to the dynamics of the face, instilling trust in their effectiveness. Coupled with the growing public awareness of cosmetic surgery, these reasons are set to push the market throughout the decade.

North America Cosmetic Surgery Market:

North America dominates the beauty surgery market due to the region's increasing concern for outward image, agreement of cutting-edge cosmetic treatments, and technological breakthroughs. Aesthetic plastic surgery info shows that not very therapies rose by 44%, while surgery operations account for 54%. 

365,000 breast enlargements was done in 2021, with women making up about 94% of all patients. Additionally, compared to 71,000 women who had their implants removed but not replaced, 148,000 women had their implants removed and replaced. Surgical operations offer 69% of overall income, even though they make up only 21%.

Europe Beauty Surgery Market:

Because of rising healthcare costs, the incidence of skin relations, and technological progress, the cosmetic surgery market in Europe sustained the second-biggest market share. For example, the British Association of Aesthetic Plastic Physicians (BAAPS) reports that almost 27,000 operations were carried out in 2019, with skin tightening being the most common surgery. Also, The Cosmetic Surgery Market in Germany is thought to have the most significant share, while The Cosmetic Surgery Market in France is expected to rise at the quickest rate in Europe.

Cosmetic Surgery Market Company Overview:

Some of the industry leads of the Global Cosmetic Surgery Market, includes AbbVie Inc., Cutera Inc., Siestra Inc., Bauch Health Firms Inc., Johnson & Johnson Services, Inc., Apex Medical, Hologic, Merz Pharma, Galderma, Cynosure.

Cosmetic Surgery Market News:

TILA Bio, Inc. introduced the OviTex PRS Long-Term Resorbable product to the American market in August 2023. This product applies to both reconstructive and plastic surgery.

Establishment Labs Holdings Inc. stated in Walk 2023 that it has signed agreements with four partners in Europe and another chain of partners in Japan to introduce Mia Femtech, a 15-minute process that increases breast shape.

In July 2022, Cutera declared that AviClear, the first and only laser treatment device authorized to treat light, average, and intense acne in the United States, has received permission.

In July 2022, BIOPLUS CO., LTD. declared that China had given a specific import license for its two sorts of hyaluronic acid fillers. Among the items were Skin Plus HYAL Implant and DeneB.

In July 2022, LightStim launched Elipsa, the first LED device to give two treatment options for wrinkles and acne. Users can use this machine at home. 

June 2022 saw the release of Cynosure's PicoSure Pro machine, which uses an improved platinum lens focus array to increase the amount of collagen and elastin in the skin and decrease pores, wrinkles, and acne scars.

In May 2022, Apyx Medical communicated that the US Food and Drug Management had permitted 510(k) to use its Renuvion Dermal Handpiece for unique dermal resurfacing.

Gender – Market breakup in 2 viewpoints:

1.    Female
2.    Male

Age Group – Market breakup in 3 viewpoints:

1.    13 to 29
2.    30 to 54 
3.    54 and above

Procedure – Market breakup in 2 viewpoints:

1.    Surgical Procedure
2.    Non-Surgical Procedure

End User – Market breakup in 3 viewpoints:

1.    Ambulatory Surgical Facility
2.    Hospital and Clinic
3.    Office and Cosmetic Surgical Center

Country – Market breakup of 25 Countries:

1.    North America

1.1    United States
1.2    Canada

2.    Europe

2.1    France
2.2    Germany
2.3    Italy
2.4    Spain
2.5    United Kingdom
2.6    Belgium
2.7    Netherlands
2.8    Turkey

3.    Asia Pacific

3.1    China
3.2    Japan
3.3    India
3.4    South Korea
3.5    Thailand
3.6    Malaysia
3.7    Indonesia
3.8    Australia
3.9    New Zealand

4.    Latin America

4.1    Brazil
4.2    Mexico
4.3    Argentina

5.    Middle East & Africa

5.1    Saudi Arabia
5.2    UAE
5.3    South Africa

All the Key players have been covered from 4 Viewpoints:

1.    Overview
2.    Recent Development
3.    Product Portfolio
4.    Financial Insights

Company Analysis:

1.    AbbVie Inc.
2.    Cutera Inc.
3.    Sientra Inc.
4.    Bausch Health Companies Inc.
5.    Johnson & Johnson Services, Inc. 
6.    Apyx Medical
7.    Hologic
8.    Merz Pharma
9.    Galderma
10.    Cynosure

Report Details: